Skip to main content

Table 1 Clinical information

From: Multimodal analysis using [11C]PiB-PET/MRI for functional evaluation of patients with Alzheimer’s disease

GroupAge (years old)SexVSRADPerfusion SPECTMMSEADAS
AD (N = 27)69 ± 12M 13
F 14
1.86 ± 0.99s/o DAT 14
s/o FTD 4
WNL 3
24 ± 3*15 ± 8
CTL (N = 16)68 ± 11M 9
F 7
1.27 ± 0.7829 ± 1
  1. Perfusion SPECT was performed in 21 patients using N-isopropyl-p-[123I]iodo-amphetamine (IMP)
  2. AD Alzheimer’s patients, CTL healthy controls, VSRAD voxel-based specific regional analysis system for Alzheimer’s disease, MMSE Mini-Mental State Examination, ADAS Alzheimer’s Disease Assessment Scale-Cognitive Subscale, DAT dementia of Alzheimer’s type, FTD frontotemporal dementia
  3. *P < 0.00001